People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the ...

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analog class, better ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the ...

These drugs work to treat diabetes and weight loss by suppressing the appetite and lowering blood sugar and A1C—which may end ...

Novo Nordisk CEO Lars Jørgensen will testify about the high cost of Ozempic and Wegovy at an upcoming HELP Committee hearing on September 24th.

A woman who used the semaglutide drugs Wegovy and Ozempic to lose weight and treat diabetes says the drugmaker didn't ...

Semaglutide did not increase the risk of depression, suicidal thoughts or suicidal behavior in people without known mental ...

Extreme hunger is common after people stop taking GLP-1 drugs like Ozempic and Wegovy, but health experts say these simple ...

Semaglutide is sold as Ozempic to treat Type 2 diabetes and as Wegovy for obesity. Wegovy is typically prescribed at a slightly higher dosage than Ozempic. Saxenda and Victoza contain liraglutide ...

A Pennsylvania mom is suing the maker of Ozempic and Wegovy claiming she nearly died from taking the prescription drugs and ...

Novo Nordisk presented data on its next-generation weight-loss candidate, amycretin, which showed a significant 13% weight ...

While GLP-1 medications like Ozempic and Wegovy hold promise for both weight loss and diabetes management, their potential for accidental misuse requires caution.